ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants

Core Insights - ASP Isotopes is preparing for a secondary listing on the Johannesburg Stock Exchange (JSE), with trading expected to commence on August 27, 2025 [3] - The company has successfully shipped its first samples of enriched Silicon-28 to a US customer and anticipates completing the enrichment of Ytterbium-176 by the end of August 2025 [2][5] - The management team will participate in a RedChip Investor call on August 28, 2025, to provide updates on operations and engage with investors [3][16] Corporate Updates - ASP Isotopes has commenced commercial production of Silicon-28 since late March 2025 and shipped its first samples in August 2025 [5] - The company began commercial production of Ytterbium-176 in April 2025, achieving an enrichment factor of 52, with plans to complete the final enrichment batch by the end of August 2025 [7][8] - The company is also enriching Carbon-12 to 99.99% and expects to supply its first commercial product in September 2025, following delays due to regulatory inspections [12] Production and Technology - The company utilizes the Aerodynamic Separation Process (ASP technology) for isotope enrichment, focusing on producing isotopes for healthcare and technology industries [17][18] - ASP Isotopes is transitioning its Ytterbium-176 enrichment plant to a semi-continuous processing method to increase production capacity, despite experiencing a slight delay due to supply chain issues [8] - The company has received permits to import equipment for the enrichment of Nickel-64, Gadolinium-160, and Zinc-68, indicating expansion plans for additional isotopes [9] Market Demand - There is a growing demand for highly enriched Silicon-28 for next-generation semiconductors, which can conduct heat 150% more efficiently than natural Silicon [6] - The company is assessing the potential to expand its Carbon enrichment facility to meet the high demand for both Carbon-12 and Carbon-14 isotopes [12] - The market for isotopes such as Molybdenum-100, Ytterbium-176, and Nickel-64 is expanding, driven by emerging healthcare applications and green energy initiatives [18]